‘Expresso Vaccines’ and Lessons from the American Chestnut Tree
‘Expresso Vaccines’ and Lessons from the American Chestnut Tree Why a vaccine designed in two days faced less regulatory scrutiny than a venerable nut tree that sustained life for centuries Dr. Mathew Maavak A tree that once fed multitudes now faces a decade of federal red tape before a single seed can touch wild soil, while a brand-new genetic vaccine, cooked up in 48 hours and injected into billions, sailed through approval in under a year. One restores a vanished forest, the other rewrote human cells on a planetary scale. Both are genetic modifications, yet one is treated as a potential ecological threat while the other is hailed as a modern miracle. Welcome to the “expresso lane” of modern biotechnology, where speed, risk, and scrutiny depend entirely on whose veins are on the line. Reign of the Chestnut King In the ancient forests of Appalachia, the American Chestnut (Castanea dentata) once towered as the unmatched monarch. Stretching from the southern ridges to southern Can...
